Ra Capital Management, L.P. Aclaris Therapeutics, Inc. Transaction History
Ra Capital Management, L.P.
- $4.82 Billion
- Q1 2025
A detailed history of Ra Capital Management, L.P. transactions in Aclaris Therapeutics, Inc. stock. As of the latest transaction made, Ra Capital Management, L.P. holds 4,666,667 shares of ACRS stock, worth $6.58 Million. This represents 0.15% of its overall portfolio holdings.
Number of Shares
4,666,667
Previous 4,666,667
-0.0%
Holding current value
$6.58 Million
Previous $11.6 Million
38.3%
% of portfolio
0.15%
Previous 0.19%
Shares
3 transactions
Others Institutions Holding ACRS
# of Institutions
112Shares Held
92.9MCall Options Held
35.4KPut Options Held
32K-
Bml Capital Management, LLC Zionsville, IN14.3MShares$20.1 Million17.65% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA9.63MShares$13.6 Million0.03% of portfolio
-
Vivo Capital, LLC Palo Alto, CA8.89MShares$12.5 Million3.69% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD5.05MShares$7.12 Million0.46% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.97MShares$7.01 Million0.0% of portfolio
About Aclaris Therapeutics, Inc.
- Ticker ACRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 66,671,800
- Market Cap $94M
- Description
- Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...